We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-2.54%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$49.4B
AUM Growth
-$1.83B
(-3.6%)
Cap. Flow
+$236M
Cap. Flow
% of AUM
0.48%
Top 10 Holdings %
Top 10 Hldgs %
23.11%
Holding
2,899
New
506
Increased
652
Reduced
806
Closed
772
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.93B |
| 2 |
Kenvue
KVUE
|
+$537M |
| 3 |
Humana
HUM
|
+$477M |
| 4 |
AbbVie
ABBV
|
+$441M |
| 5 |
Microsoft
MSFT
|
+$384M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$747M |
| 2 |
Apple
AAPL
|
+$565M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$467M |
| 4 |
McKesson
MCK
|
+$347M |
| 5 |
Intel
INTC
|
+$300M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.79% |
| 2 | Healthcare | 17.06% |
| 3 | Consumer Discretionary | 12.96% |
| 4 | Consumer Staples | 7.45% |
| 5 | Financials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Liberty Live Group Series C
LLYVK
$9.55B
| $353K | ﹤0.01% |
+11,000
| New | +$364K |
|
|
LGTY
1802
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $352K | ﹤0.01% |
30,674
+6,065
| +25% | +$67.3K |
|
1803
Cadiz
CDZI
$254M
| $351K | ﹤0.01% |
106,100
-47,215
| -31% | -$181K |
|
1804
Milestone Pharmaceuticals
MIST
$133M
| $351K | ﹤0.01% |
113,187
-53,914
| -32% | -$168K |
|
1805
iShares ESG MSCI USA Leaders ETF
SUSL
$1.12B
| $350K | ﹤0.01% |
+4,635
| New | +$363K |
|
|
CMBT
1806
CMB.TECH NV
CMBT
$4.47B
| $349K | ﹤0.01% |
21,265
-272,994
| -93% | -$4.5M |
|
|
ABLLW
1807
CALL
DELISTED
Abacus Life Warrant
ABLLW
| $349K | ﹤0.01% |
50,000
-35,415
| -41% | -$11.4K |
|
1808
PUT
Invesco CurrencyShares Japanese Yen Trust
FXY
$426M
| $348K | ﹤0.01% |
5,600
+5,000
| +833% | +$322K |
|
1809
PDS Biotechnology
PDSB
$38.6M
| $347K | ﹤0.01% |
68,795
-4,425
| -6% | -$24.2K |
|
1810
ZTO Express
ZTO
$18.1B
| $347K | ﹤0.01% |
14,352
-558,424
| -97% | -$14.2M |
|
1811
Apogee Enterprises
APOG
$875M
| $346K | ﹤0.01% |
7,355
-17,945
| -71% | -$872K |
|
1812
Hovnanian Enterprises
HOV
$810M
| $346K | ﹤0.01% |
3,400
+1,100
| +48% | +$116K |
|
1813
America's Car Mart
CRMT
$27.6M
| $345K | ﹤0.01% |
+3,794
| New | +$396K |
|
1814
Viasat
VSAT
$9.9B
| $345K | ﹤0.01% |
18,684
-132,109
| -88% | -$3.78M |
|
1815
SurgePays
SURG
$5.92M
| $345K | ﹤0.01% |
73,687
-73,703
| -50% | -$382K |
|
|
GRCL
1816
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $344K | ﹤0.01% |
119,489
-106,139
| -47% | -$388K |
|
1817
Murphy USA
MUSA
$11.1B
| $342K | ﹤0.01% |
+1,000
| New | +$318K |
|
|
DENN
1818
DELISTED
Denny's
DENN
| $340K | ﹤0.01% |
40,100
-47,500
| -54% | -$481K |
|
1819
Fulgent Genetics
FLGT
$562M
| $338K | ﹤0.01% |
12,632
+6,416
| +103% | +$219K |
|
1820
Costamare
CMRE
$1.86B
| $336K | ﹤0.01% |
+34,911
| New | +$356K |
|
1821
B2Gold
BTG
$5.2B
| $335K | ﹤0.01% |
115,855
-294,845
| -72% | -$959K |
|
1822
UNIFI
UFI
$122M
| $334K | ﹤0.01% |
+47,048
| New | +$349K |
|
|
NGD
1823
DELISTED
New Gold Inc
NGD
| $334K | ﹤0.01% |
366,539
-674,981
| -65% | -$719K |
|
1824
Mettler-Toledo International
MTD
$27.9B
| $332K | ﹤0.01% |
300
-38,268
| -99% | -$46.9M |
|
1825
Alpha and Omega Semiconductor
AOSL
$881M
| $331K | ﹤0.01% |
+11,094
| New | +$345K |
|
Similar funds
Marshall Wace's Q3 2023 Portfolio in Review
As of Q3 2023, Marshall Wace held 2,899 positions worth $49.4B, down 3.6% from $51.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Marshall Wace's Q3 2023 filing shows 506 new, 652 increased, 806 reduced and 772 closed positions. Its largest new stake was Humana: 1,014,185 shares worth $493M. The largest sale was Amazon, an estimated $747M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q3 2023 buy was Humana: 1,014,185 shares worth $493M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q3 2023, an estimated $1.93B increase.
- Marshall Wace's biggest Q3 2023 reduction was Amazon, cutting an estimated $747M.
- Marshall Wace fully exited Johnson & Johnson in Q3 2023, selling an estimated $284M.
- Marshall Wace's ten largest holdings make up 23% of its $49.4B portfolio in Q3 2023.
- Marshall Wace opened 506 new positions and closed 772 in Q3 2023.
- Marshall Wace's portfolio value fell 3.6% quarter-over-quarter to $49.4B.
Based on Marshall Wace's 13F filing for Q3 2023, filed 14 Nov 2023.